Filing Details

Accession Number:
0001375151-22-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-21 21:23:47
Reporting Period:
2022-01-19
Accepted Time:
2022-01-21 21:23:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1375151 Zogenix Inc. ZGNX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1051411 T Erle Mast C/O Zogenix, Inc.
5959 Horton Street, Suite 500
Emeryville CA 94608
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Stock Option (Right To Buy) Acquisiton 2022-01-19 6,250 $15.04 9,277 No 4 M Direct
Stock Option (Right To Buy) Acquisiton 2022-01-19 4,375 $14.88 13,652 No 4 M Direct
Stock Option (Right To Buy) Acquisiton 2022-01-19 4,375 $12.00 18,027 No 4 M Direct
Stock Option (Right To Buy) Disposition 2022-01-19 15,000 $26.09 3,027 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2022-01-19 6,250 $0.00 6,250 $15.04
Common Stock Stock Option (Right to Buy) Disposition 2022-01-19 4,375 $0.00 4,375 $14.88
Common Stock Stock Option (Right to Buy) Disposition 2022-01-19 4,375 $0.00 4,375 $12.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2022-04-27 No 4 M Direct
0 2022-06-06 No 4 M Direct
1,250 2023-06-18 No 4 M Direct
Footnotes
  1. The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2021.
  2. Represents the weighted average sales price per share. The shares were sold at prices ranging from $26.05 to $26.15 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  3. All of the shares subject to this option are fully vested and exercisable as of the date hereof.